REXFLAVONE_For Menopause Relief

Passed a thorough quality control system and it's given a certification mark guaranteed by NOVAREX.

What's all about REXFLAVONE?

→ Rexflavone™ features a patented, clinically proven phyto-extract that is effective on improvment of compliant postmenopausal symptoms without significant adverse effects. Research has shown REXFLAVONE significantly improved 11 menopausal symptoms including hot flash, insomnia, fatigue, and headache, which were evaluated by the modified Kupperman Index (KI). REXFLAVONE has been notified as a New Dietary Ingredient (NDI) by the U.S. Food and Drug Administration (FDA).
 

→ Rexflavone™ has completed all types of safety studies including the Human clinical studies, Acute toxicity studies, Dose range-finding studies, Repeated toxicity studies, and Genetic toxicology studies.

[REXFLAVONE]

Product Information

[Ingredients]

Rexflavone (Sophora Japonica Linne Fruit Extract), Sophoricoside, Dextrin, Microcrystalline cellulose, Milk salts, Hydroxypropyl methylcelluslose, Carboxymethylcellulose calcium, Magnesium stearate, Glycerin fatty acid ester, Hibiscus extract, and fish collagen

[Net Weight] 60 Tablets X 700mg

[Dosage and Method] 2 Tablets per day

[Manufacturer] Novarex Co., Ltd.

[Country of Manufacturing] South Korea

[Shelf Life] 2 years

[Caution] Do not exceed recommended dose. Pregnant or nursing mothers, children under 18, and individuals with a known medical condition should consult a physician before using this or any dietary supplement. If you are taking a birth control pill, are considering becoming pregnant or have questions about the advisability of taking this product, consult your physician prior to use. This product is manufactured and packaged in a facility which may also process milk, soy, wheat, eggs, peanuts, tree nuts, fish and crustacean shellfish. Produced in a GMP facility that processes other ingredients containing these allergens.

The mechanism of RexFlavone on menopause is for the phytoestrogen chemical compounds to bind with the same cellular estrogen binding sites through competitive inhibition.
As for postmenopausal symptoms, studies suggest that women with high estrogen levels can replace these phytoestrogens into estrogens thus creating a more delayed estrogenic activity. Contrarily, women with low estrogen levels can replace these lost estrogen activities by creating a more rapid result of more estrogen levels.